Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04740177
Other study ID # RECHMPL20_0119
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 1, 2020
Est. completion date December 30, 2020

Study information

Verified date January 2021
Source University Hospital, Montpellier
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Congenital heart disease (CHD) is the leading cause of birth defects, with an incidence of 0.8%. Since the 1980s, France has been a pioneer in neonatal CHD surgery (Pr. Fontan, Pr. Lecomte, Pr. Serraf, etc.), in prenatal diagnosis, and in interventional cardiac catheterization. Actually, first children operated for complex CHD have reached adulthood and a new epidemiology of CHD is emerging. Currently, one of the public health challenges is the need to maintain appropriate follow-up and to avoid disruption of care during the transition from adolescence to adulthood. Thus, the national health authorities (DGOS) recently certified a national network of expert centers for complex CHD (M3C). In addition, under the leadership of the French Society of Cardiology, the sub-specialty of Pediatric and Congenital Cardiology has been recognized. However, while North American and North European countries have published their updated data on the main indicators of CHD morbidity and mortality, no study has reported epidemiology of CHD in France. Currently, available data are approximate, estimating that 200,000 children and 250,000 adults would be living in France with a CHD. Nevertheless, no information is available on hospitalizations, type of CHD, their follow-up, possible disruption in care, and morbidity and mortality in patients with CHD in France. This epidemiological study will use the national health insurance hospital database to answer these questions.


Description:

Retrospective epidemiological study based on the national health insurance hospital database from 2010 to 2020 (10 years): Main objective: • To assess the prevalence of patients with CHD hospitalized in France over 10 years. Secondary objectives: asess over the same period: - Overall mortality rate according to the CHD classification and the geographic area - Overall morbidity rate, according to the CHD classification and the geographic area - Overall cardiac surgery-related mortality rate (cardiac surgery and other surgery), according to the CHD classification (adjusted for the severity of the CHD and the surgical procedure) and to geographic area - Overall cardiac catheter-related mortality rate, according to the CHD classification (adjusted for the severity of the CHD and the catheterization procedure) and to geographic area - CHD follow-up within and outside the national M3C network - Periods of loss of cardiological follow-up (within or outside the M3C network, in hospital or in town) - Obstetrical data for women (parity, pregnancy) - The existence of a prenatal diagnosis (yes / no and the term of pregnancy at the time of diagnosis of CHD)


Recruitment information / eligibility

Status Completed
Enrollment 450000
Est. completion date December 30, 2020
Est. primary completion date December 1, 2020
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion criteria: - Patient (of any age) with a CHD as defined by the international ACC-CHD classification and listed in the ICD10 classification, hospitalized from 01/01/2010 to 12/31/2019 in a French tertiary care hospital from the M3C network. Exclusion criteria: - Patient with non-malformative genetic heart disease (cardiomyopathy, hereditary rhythmic disease).

Study Design


Locations

Country Name City State
France Uh Montpellier Montpellier

Sponsors (3)

Lead Sponsor Collaborator
University Hospital, Montpellier National Reference Center for Complex Congenital Heart Disease, Marie-Lannelongue Medical and Surgical Center, Le Plessis Robinson, National Reference Center for Complex Congenital Heart Disease, University Hospital of Bordeaux

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of patients with CHD hospitalized in France Rate of patients with CHD hospitalized in France 10 years
Secondary Rate of mortality in patients with CHD Rate of mortality in patients with CHD 10 years
Secondary Rate of cardiac surgery-related mortality in patients with CHD Rate of cardiac surgery-related mortality in patients with CHD 10 years
Secondary Rate of cardiac catheter-related mortality in patients with CHD Rate of cardiac catheter-related mortality in patients with CHD 10 years
Secondary Rate of CHD patient's loss to follow-up within and outside the national M3C network Rate of CHD patient's loss to follow-up within and outside the national M3C network 10 years
Secondary Rate of CHD prenatal diagnosis Rate of CHD prenatal diagnosis 10 years
See also
  Status Clinical Trial Phase
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT04992793 - Paediatric Brain Injury Following Cardiac Interventions
Recruiting NCT05213598 - Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment
Completed NCT04136379 - Comparison of Home and Standard Clinic Monitoring of INR in Patients With CHD
Completed NCT04814888 - 3D Airway Model for Pediatric Patients
Recruiting NCT04920643 - High-exchange ULTrafiltration to Enhance Recovery After Pediatric Cardiac Surgery N/A
Completed NCT05934578 - Lymphatic Function in Patients With Fontan Circulation: Effect of Physical Training N/A
Recruiting NCT06041685 - Effect of Local Warming for Arterial Catheterization in Pediatric Anesthesia N/A
Recruiting NCT05902013 - Video Laryngoscopy Versus Direct Laryngoscopy for Nasotracheal Intubation N/A
Not yet recruiting NCT05687292 - Application of a Clinical Decision Support System to Reduce Mechanical Ventilation Duration After Cardiac Surgery
Not yet recruiting NCT05524324 - Cardiac Resynchronization Therapy in Adult Congenital Heart Disease With Systemic Right Ventricle: RIGHT-CRT N/A
Completed NCT02746029 - Cardiac Murmurs in Children: Predictive Value of Cardiac Markers
Completed NCT03119090 - Fontan Imaging Biomarkers (FIB) Study
Completed NCT02537392 - Multi-micronutrient Supplementation During Peri-conception and Congenital Heart Disease N/A
Recruiting NCT02258724 - Swiss National Registry of Grown up Congenital Heart Disease Patients
Completed NCT01966237 - Milrinone Pharmacokinetics and Acute Kidney Injury
Terminated NCT02046135 - Sodium Bicarbonate to Prevent Acute Kidney Injury in Children Undergoing Cardiac Surgery Phase 2
Recruiting NCT01184404 - Bosentan Improves Clinical Outcome of Adults With Congenital Heart Disease or Mitral Valve Lesions Who Undergo CArdiac Surgery N/A
Completed NCT01548950 - Drug Therapy and Surgery in Congenital Heart Disease With Pulmonary Hypertension N/A
Completed NCT01178710 - Effect of Simvastatin on Cardiac Function N/A